4.7 Article

Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 79, Issue 17, Pages 1647-1655

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2022.02.032

Keywords

alcohol septal ablation; hypertrophic cardiomyopathy; left ventricular outflow tract obstruction; septal myectomy; septal reduction therapy

Funding

  1. Paul and Ruby Tsai and Family

Ask authors/readers for more resources

This study compared the long-term mortality of patients with obstructive HCM who underwent septal myectomy or ASA. The results showed that ASA was associated with higher all-cause mortality compared to septal myectomy.
BACKGROUND There is little information regarding tong-term mortality comparing the 2 most common procedures for septal reduction for obstructive hypertrophic cardiornyopathy (HCM), alcohol septat ablation (ASA), and septat myectomy. OBJECTIVES This study sought to compare the long-term mortality of patients with obstructive HCM following septat myectomy or ASA. METHODS We evaluated outcomes of 3,859 patients who underwent ASA or septat myectomy in 3 specialized HCM centers. All-cause mortality was the primary endpoint of the study. RESULTS In the study cohort, 585 (15.2%) patients underwent ASA, and 3,274 (84.8%) underwent septal myectomy. Patients undergoing ASA were significantly older (median age: 63.0 years [IQR: 52.7-72.8 years] vs 53.7 years [IQR: 44.9-62.8 years]; P < 0.001) and had smaller septat thickness (19.0 mm [IQR: 17.0-22.0 mm] vs 20.0 mm [IQR: 17.0-23.0 mm]; P = 0.007). Patients undergoing ASA also had more comorbidities, including renal failure, diabetes, hypertension, and coronary artery disease. There were 4 (0.7%) early deaths in the ASA group and 9 (0.3%) in the myectomy group. Over a median follow-up of 6.4 years (IQR: 3.6-10.2 years), the 10-year all-cause mortality rate was 26.1% in the ASA group and 8.2% in the myectomy group. After adjustment for age, sex, and comorbidities, the mortality remained greater in patients having septal reduction by ASA (HR: 1.68; 95% CI: 1.29-2.19; P < 0.001). CONCLUSIONS In patients with obstructive hypertrophic cardiornyopathy, ASA is associated with increased long-term all-cause mortality compared with septal myectomy. This impact on survival is independent of other known factors but may be influenced by unmeasured confounding patient characteristics. (C) 2022 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available